Bacitracin, neomycin (Nebacetin)
Bacitracin, neomycin
Byk Gulden SA (Pty) Ltd*
Every registration of this product has been cancelled.
Registration
- Applicant
- Byk Gulden SA (Pty) Ltd*
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nebacetin ointment 1 G BACITRACIN A 250 IU NEOMYCIN SULPHATE A 5,0 MG | Ointment | G2377 | Cancelled | Not determined | None |
| Nebacetin powder 1 G BACITRACIN A 250 IU NEOMYCIN SULPHATE A 5,0 MG | Powder | G2378 | Cancelled | Not determined | None |
| Nebacetin spray powder 1 G BACITRACIN A 12 500 IU NEOMYCIN SULPHATE A 162 5000 IU | Spray powder | G2379 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Bacitracin
- except when intended for topical application to the epidermis, nares and external ear. (S1) and except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 5417 to 5419
S4: Neomycin
- except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).
Consolidated Schedules 06 July 2026, lines 7224 to 7225
S1: Bacitracin
- when intended for topical application to the epidermis, nares and external ear.
Consolidated Schedules 06 July 2026, line 148
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.